|
序 列 ： |
The synthetic peptide used to raise the antibody Cat. No. 251343 is selected from a sequence within the N-term region of mouse NaPi-2b. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended. |
| 分 子 式 ： |
C57H100N16O22 |
|
分 子 量 ： |
1360.7 g/mol |
|
純 度 ： |
Purity > 80% by HPLC |
|
形 態 ： |
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect. |
|
溶 解： |
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile. |
|
保存條件 ： |
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C. |
| 別 名 ： |
SLC34A2; NaPi-2b; Sodium-dependent phosphate transport 2B; Sodium-phosphate transport protein 2B; Na(+)-dependent phosphate cotransporter 2B; Sodium/phosphate cotransporter 2B; Na(+)/Pi cotransporter 2B; NaPi3b; Solute carrier family 34 member 2 |
| 產品鏈接 ： |
http://www.ABBIOTEC.com/peptides/napi-2b-peptide |
|
產品說明 ： |
|
| 產品描述 ： |
Sodium-dependent phosphate transport protein 2B (NaPi-2b) is involved in actively transporting phosphate into cells via Na+ co-transport. NaPi-2b is the main phosphate transport protein in the intestinal brush border membrane, and has a role in the synthesis of surfactant in lungs' alveoli. Defects in NaPi-2b are a cause of pulmonary alveolar microlithiasis, a rare disease characterized by the deposition of calcium phosphate microliths throughout the lungs. |
